Consult an Expert
Trademark
Design Registration
Consult an Expert
Trademark
Copyright
Patent
Infringement
Design Registration
More
Consult an Expert
Consult an Expert
Trademark
Design Registration
Login
/
OSTIVION (1) AVIATIK PHARMA PRIVATE LIMITED THROUGH THE DIRECTOR THAKUR RITESH CHANDRA AND BINDHYACHAL PANDEYBody Incorporate
O
OSTIVION
(1) AVIATIK PHARMA PRIVATE LIMITED THROUGH THE DIRECTOR THAKUR RITESH CHANDRA AND BINDHYACHAL PANDEYBody Incorporate
OSTIVION is a Trademark filed on Feb 16, 2018 in through IP Office.The Trademark is registered to (1) AVIATIK PHARMA PRIVATE LIMITED THROUGH THE DIRECTOR THAKUR RITESH CHANDRA AND BINDHYACHAL PANDEYBody Incorporate and was filed by attorney.
O
OSTIVION (1) AVIATIK PHARMA PRIVATE LIMITED THROUGH THE DIRECTOR THAKUR RITESH CHANDRA AND BINDHYACHAL PANDEYBody Incorporate Trademark Information
Application ID
3755087
Status
Abandoned
Date of Application
Feb 16, 2018
Classes
5
Proprietor(s)
(1) AVIATIK PHARMA PRIVATE LIMITED THROUGH THE DIRECTOR THAKUR RITESH CHANDRA AND BINDHYACHAL PANDEYBody Incorporate
Published
May 07, 2018
FAQ's for OSTIVION (1) AVIATIK PHARMA PRIVATE LIMITED THROUGH THE DIRECTOR THAKUR RITESH CHANDRA AND BINDHYACHAL PANDEYBody Incorporate Trademark
The application for OSTIVION was made on Feb 16, 2018
The trademark applicant for OSTIVION is (1) AVIATIK PHARMA PRIVATE LIMITED THROUGH THE DIRECTOR THAKUR RITESH CHANDRA AND BINDHYACHAL PANDEYBody Incorporate.
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Abandoned.
Listed application Id of OSTIVION is 3755087.
OSTIVION Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
Don’t lose your brand like ””
Our experts are here to assist you in finding a similar trademark.
Our experts are here to assist you in finding a similar trademark.
4.5
(18k+ reviews)
1 Lakh+
TM Registered since 2011
